Paul Edward Kelly, Director at RELMADA THERAPEUTICS, INC. (RLMD), sold 1,800 shares at $35.43 ($64K) on 2021-01-22, disclosed to the SEC on 2021-01-27.
Open-market sale of $64k RLMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RLMD | BUY | 2024-09-11 | $65K | — | Filing → |
| RLMD | SELL | 2022-04-05 | $300K | — | Filing → |
| RLMD | SELL | 2021-03-11 | $357K | — | Filing → |